BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 22200614)

  • 1. Collagen VI ablation retards brain tumor progression due to deficits in assembly of the vascular basal lamina.
    You WK; Bonaldo P; Stallcup WB
    Am J Pathol; 2012 Mar; 180(3):1145-1158. PubMed ID: 22200614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pericyte deficiencies lead to aberrant tumor vascularizaton in the brain of the NG2 null mouse.
    Huang FJ; You WK; Bonaldo P; Seyfried TN; Pasquale EB; Stallcup WB
    Dev Biol; 2010 Aug; 344(2):1035-46. PubMed ID: 20599895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early vascular deficits are correlated with delayed mammary tumorigenesis in the MMTV-PyMT transgenic mouse following genetic ablation of the NG2 proteoglycan.
    Gibby K; You WK; Kadoya K; Helgadottir H; Young LJ; Ellies LG; Chang Y; Cardiff RD; Stallcup WB
    Breast Cancer Res; 2012 Apr; 14(2):R67. PubMed ID: 22531600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The NG2 Proteoglycan in Pericyte Biology.
    Stallcup WB
    Adv Exp Med Biol; 2018; 1109():5-19. PubMed ID: 30523586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NG2 proteoglycan promotes tumor vascularization via integrin-dependent effects on pericyte function.
    You WK; Yotsumoto F; Sakimura K; Adams RH; Stallcup WB
    Angiogenesis; 2014 Jan; 17(1):61-76. PubMed ID: 23925489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular abnormalities and development of hypoxia in microscopic melanoma xenografts.
    Gaustad JV; Simonsen TG; Andersen LMK; Rofstad EK
    J Transl Med; 2017 Nov; 15(1):241. PubMed ID: 29183378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid vascular regrowth in tumors after reversal of VEGF inhibition.
    Mancuso MR; Davis R; Norberg SM; O'Brien S; Sennino B; Nakahara T; Yao VJ; Inai T; Brooks P; Freimark B; Shalinsky DR; Hu-Lowe DD; McDonald DM
    J Clin Invest; 2006 Oct; 116(10):2610-21. PubMed ID: 17016557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of vascular endothelial growth factor (VEGF) signaling in cancer causes loss of endothelial fenestrations, regression of tumor vessels, and appearance of basement membrane ghosts.
    Inai T; Mancuso M; Hashizume H; Baffert F; Haskell A; Baluk P; Hu-Lowe DD; Shalinsky DR; Thurston G; Yancopoulos GD; McDonald DM
    Am J Pathol; 2004 Jul; 165(1):35-52. PubMed ID: 15215160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor vessel biology in pediatric intracranial ependymoma.
    Wagemakers M; Sie M; Hoving EW; Molema G; de Bont ES; den Dunnen WF
    J Neurosurg Pediatr; 2010 Apr; 5(4):335-41. PubMed ID: 20367336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The critical role of mast cell-derived hypoxia-inducible factor-1α in human and mice melanoma growth.
    Jeong HJ; Oh HA; Nam SY; Han NR; Kim YS; Kim JH; Lee SJ; Kim MH; Moon PD; Kim HM; Oh HA
    Int J Cancer; 2013 Jun; 132(11):2492-501. PubMed ID: 23161568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular endothelial growth factor-A(165) induces progression of melanoma brain metastases without induction of sprouting angiogenesis.
    Küsters B; Leenders WP; Wesseling P; Smits D; Verrijp K; Ruiter DJ; Peters JP; van Der Kogel AJ; de Waal RM
    Cancer Res; 2002 Jan; 62(2):341-5. PubMed ID: 11809675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinct role of fibroblast growth factor-2 and vascular endothelial growth factor on tumor growth and angiogenesis.
    Giavazzi R; Sennino B; Coltrini D; Garofalo A; Dossi R; Ronca R; Tosatti MP; Presta M
    Am J Pathol; 2003 Jun; 162(6):1913-26. PubMed ID: 12759248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NG2 Proteoglycan-Dependent Contributions of Pericytes and Macrophages to Brain Tumor Vascularization and Progression.
    Stallcup WB; You WK; Kucharova K; Cejudo-Martin P; Yotsumoto F
    Microcirculation; 2016 Feb; 23(2):122-33. PubMed ID: 26465118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transition of horizontal to vertical growth phase melanoma is accompanied by induction of vascular endothelial growth factor expression and angiogenesis.
    Erhard H; Rietveld FJ; van Altena MC; Bröcker EB; Ruiter DJ; de Waal RM
    Melanoma Res; 1997 Aug; 7 Suppl 2():S19-26. PubMed ID: 9578413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The NC1 domain of type XIX collagen inhibits in vivo melanoma growth.
    Ramont L; Brassart-Pasco S; Thevenard J; Deshorgue A; Venteo L; Laronze JY; Pluot M; Monboisse JC; Maquart FX
    Mol Cancer Ther; 2007 Feb; 6(2):506-14. PubMed ID: 17308049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelial-specific Notch blockade inhibits vascular function and tumor growth through an eNOS-dependent mechanism.
    Patenaude A; Fuller M; Chang L; Wong F; Paliouras G; Shaw R; Kyle AH; Umlandt P; Baker JH; Diaz E; Tong J; Minchinton AI; Karsan A
    Cancer Res; 2014 May; 74(9):2402-11. PubMed ID: 24599126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abnormalities of basement membrane on blood vessels and endothelial sprouts in tumors.
    Baluk P; Morikawa S; Haskell A; Mancuso M; McDonald DM
    Am J Pathol; 2003 Nov; 163(5):1801-15. PubMed ID: 14578181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential expression of markers for endothelial cells, pericytes, and basal lamina in the microvasculature of tumors and granulation tissue.
    Schlingemann RO; Rietveld FJ; Kwaspen F; van de Kerkhof PC; de Waal RM; Ruiter DJ
    Am J Pathol; 1991 Jun; 138(6):1335-47. PubMed ID: 1711288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NG2 proteoglycan-dependent recruitment of tumor macrophages promotes pericyte-endothelial cell interactions required for brain tumor vascularization.
    Yotsumoto F; You WK; Cejudo-Martin P; Kucharova K; Sakimura K; Stallcup WB
    Oncoimmunology; 2015 Apr; 4(4):e1001204. PubMed ID: 26137396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stromal cell-derived factor-1 stimulates vasculogenesis and enhances Ewing's sarcoma tumor growth in the absence of vascular endothelial growth factor.
    Reddy K; Zhou Z; Jia SF; Lee TH; Morales-Arias J; Cao Y; Kleinerman ES
    Int J Cancer; 2008 Aug; 123(4):831-7. PubMed ID: 18537159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.